Botanical species · safety record

Styphnolobium japonicum

The EFSA Compendium of Botanicals holds 20 constituent measurements and 1 genotoxicity assay for Styphnolobium japonicum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Styphnolobium japonicum (L.) Schott

20Constituent measurements
1Safety records
5Cited sources
109Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 109 licensed products naming Styphnolobium japonicum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Flower
  • Flower (standardized extract)
  • Flower buds
  • Fruit
  • Seed pod
  • Styphnolobium japonicum - Flower bud
  • Styphnolobium japonicum - flower
  • Twig(s)

What the records describe

Constituents measured

  • Genistein4
  • Isoflavones3
  • Daidzein2
  • Formononetin2
  • Genistin2
  • Sophoricoside2
  • Biochanin-a1
  • Coumestrol1
  • Lignans1
  • Matairesinol1

Plant parts

  • Unspecified7
  • Fruit peel5
  • Fruit unspecified4
  • Seed4

Preparations

  • Solvent extraction20

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
GenisteinSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
GenisteinFruit unspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
GenistinSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
GenistinFruit unspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
IsoflavonesSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
IsoflavonesFruit unspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
SophoricosideFruit unspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
SophoricosideSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Biochanin-aUnspecifiedSolvent extraction830 Microgram/100 gramGC-MSNo resolvable identifier
CoumestrolUnspecifiedSolvent extraction9.9 Microgram/100 gramGC-MSNo resolvable identifier
DaidzeinUnspecifiedSolvent extraction319 Microgram/100 gramGC-MSNo resolvable identifier
DaidzeinFruit peelSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
FormononetinFruit peelSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
FormononetinUnspecifiedSolvent extraction322 Microgram/100 gramGC-MSNo resolvable identifier
GenisteinFruit peelSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
GenisteinUnspecifiedSolvent extraction265 Microgram/100 gramGC-MSNo resolvable identifier
IsoflavonesFruit peelSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
LignansUnspecifiedSolvent extraction1590 Microgram/100 gramGC-MSNo resolvable identifier
MatairesinolUnspecifiedSolvent extraction3.8 Microgram/100 gramGC-MSNo resolvable identifier
PrunetinFruit peelSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivegene mutationbacterial forward mutation assaySalmonella typhimurium (as organism)With and withoutNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Abdallah, Hossam M., Al-Abd, Ahmed M., Asaad, Gihan F., Abdel-Naim, Ashraf B., El-halawany, Ali M. Isolation of antiosteoporotic compounds from seeds of Sophora japonica.. Plos one, 2014, vol. 9, no. 6, p. e98559. DOI
  2. YIN, XJ., LIU, DX., WANG, HC., ZHOU, Y. A STUDY ON THE MUTAGENICITY OF 102 RAW PHARMACEUTICALS USED IN CHINESE TRADITIONAL MEDICINE. MUTATION RESEARCH, 1991, vol. 260, no. 1, p. 73-82.
  3. Min, B., Oh, SR., Lee, HK., Takatsu, K., Chang, IM., Min, KR., Kim, Y. Sophoricoside analogs as the IL-5 inhibitors from Sophora japonica. Planta medica, 1999, vol. 65, no. 5, p. 408-412. DOI
  4. Tang, Yuping., Lou, Fengchang., Wang, Jinghua. Isoflavonoids from the peel of Sophora japonica. Zhongcaoyao, 2002, vol. 33, no. 1, p. 20-21.
  5. Mazur, Witold M., Duke, James A., Wahala, Kristiina., Rasku, Sirpa., Adlercreutz, Herman. Isoflavonoids and lignans in legumes: nutritional and health aspects in humans. Journal of nutritional biochemistry, 1998, vol. 9, no. 4, p. 193-200.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue